Revealing the complex interaction between trans-and cis-regulatory elements and identifying these potential binding sites are fundamental problems in understanding gene expression. The progresses in ChIP-chip technology facilitate identifying DNA sequences that are recognized by a specific transcription factor. However, protein-DNA binding is a necessary, but not sufficient, condition for transcription regulation. We need to demonstrate that their gene expression levels are correlated to further confirm regulatory relationship. Here, instead of using a linear correlation coefficient, we used a non-linear function that seems to better capture possible regulatory relationships. By analyzing tissue-specific gene expression profiles of human and mouse, we delineate a list of pairs of transcription factor and gene with highly correlated expression levels, which may have regulatory relationships. Using two closely-related species (human and mouse), we perform comparative genome analysis to cross-validate the quality of our prediction. Our findings are confirmed by matching publicly available TFBS databases (like TRANFAC and ConSite) and by reviewing biological literature. For example, according to our analysis, 80% and 85.71% of the targets genes associated with E2F5 and RELB transcription factors have the corresponding known binding sites. We also substantiated our results on some oncogenes with the biomedical literature. Moreover, we performed further analysis on them and found that BCR and DEK may be regulated by some common transcription factors. Similar results for BTG1, FCGR2B and LCK genes were also reported.
Introduction
The completion of the Human Genome Project (HGP) [1] [2] [3] signifies not the end of a journey but rather the beginning of an exciting expedition in revealing the secret of the human genome. To be truly benefited from the HGP, we still need to decipher the biological connotation of the sequences; otherwise, these are just some long strings of meaningless letters. The natural next step is to identify the functional elements in the human genome and understand how the genes regulate and interact with each other. While a large number of human genes have been identified, their regulatory mechanism remains mostly unknown even at the transcriptional level [4] .
The main mechanism of transcriptional control is to bind transcription factors (TF) to ciselements (TFBS a.k.a. transcription factor binding sites) either upstream or downstream of the regulated gene, scattered all along thousands of base pairs in both intergenic and intragenic regions. In doing so, it either enhances or suppresses gene transcription. To some extent, trans-elements can be viewed as "keys" needed to unlock the cis-elements which act as "locks". To comprehend gene transcription mechanism, it is not sufficient to know which keys (trans-elements) are needed to lock/unlock a specific gene, but we also need to identify their corresponding locks (cis-elements). Moreover, identification of binding sites serves as a form of validation on the putative trans-elements. If we are able to identify a putative ciselement, say a conserved sequence element, which is over-represented in the genes that we believe to be regulated by a particular transcription factor then it is more plausible that the TF acts as a trans-element.
In silico discovery [5] of binding sites is quite effective for prokaryotes, like Escherichia coli [6, 7] , where genomes are more compact with many genes being regulated by a single operator that is relatively easy to locate. Similar successes have been reported for simple unicellular eukaryotes, like Saccharomyces cerevisiae [8] [9] [10] . The main approach for finding regulatory elements of such simple organisms is to search for overrepresented motifs modeled by known background profiles, such as position weighted matrices (PWMs) [11] [12] [13] [14] [15] [16] [17] , position specific score matrices (PSSMs) [11, 18, 19] , while some use clustering to demarcate cisregulatory modules [20, 21] . For higher multi-cellular eukaryotes, model-based approaches [4, [22] [23] [24] that discover patterns among co-expressed genes with respect to regulating transcription factors, have been proposed. The idea behind these techniques involves the proximity of common cis-regulatory modules among the co-expressed genes. Among other common model-based (a.k.a. machine learning) techniques, artificial neural networks [25] , greedy algorithm [12] , Gibbs Sampling [26] , Markov chains [27, 28] , Expectation Maximization (EM) algorithm [29] are widely used for eukaryotes. However, it has been reported that these model-prediction techniques are susceptible to high false positive prediction rate and majority of predicted TFBS generated with predictive models (in silico) have no functional role in vivo [14] .
To overcome this potential shortcoming, quite a number of algorithms have been presented motivated by "phylogenetic footprinting" [30] [31] [32] [33] , which is based on searching for similarity in sequences due to selective pressure during evolution,. In fact, phylogenetic footprinting complements the computational approaches, as sequence conservation across lineage reveals segments in genes that might delineate common biological functions. So, to identify regulatory regions, orthologous genes at the sequence level are compared. The underlying hypothesis that inspires phylogeny as a powerful scheme is that sequences related to vital biological functions will be retained under evolutionary selective pressure [34, 35] . It is assumed that the orthologous genes are accountable to the same regulatory mechanisms in different species. Again, phylogenetic footprinting algorithms can detect putative binding sites if it meets two criteria: (1) sequences from organisms with adequate evolutionary distance share the same conserved regions, and (2) TFBS are over-represented in the proximity. Thus novel methods using cross-species genome comparison can significantly improve the overall specificity of predictions [36, 37] .
Jin et al. [38, 39] analyzed conserved human-mouse orthologous gene pairs to find core promoter elements and Bussemaker et al. [23] addressed the issue of detecting regulatory elements using correlation of expressions. A recent paper by Kim et al. [40] dealt with predicting transcriptional regulatory elements of human promoters using gene expression and promoter analysis data, which compare two pools of genes using z-scores. Our aim here is to find both trans-and cis-elements in the human genome. Further, to ensure better quality of our analysis, we also used mouse tissue-specific gene expression profile and the observation that functional elements tend to be conserved between mouse and human.
genome [42, 43] , genome-scale interspecies comparison techniques have evolved [44] , and geneticists have been amazed by the incredible resemblance between human and mouse genomes. In numbers, almost 40% of total nucleotides show exact matches in global alignments [45] , and about 93.2% of identical nucleotides has been observed in conserved regions [46] . Moreover, the mouse-model is extensively used to study the molecular foundation and therapy of certain diseases, as functionally related genes are preferentially retained in conserved regions [47] .
Based on the flavor of the both strategies of phylogenetic footprinting and co-regulated gene expression profiles, in this paper we propose a systematic approach to identify putative transcriptional regulatory elements in both human and mouse genomes. Our algorithm delineates potential TF-gene pairs by analyzing tissue-specific gene expression data of both human and mouse. As a means of validation, we restrict our attention to orthologous TFs and genes that share a common gene symbol between the two species, and validate our findings by comparing against a widely used TFBS profile registry and reviewed literature.
To investigate the efficacy of our technique and utility of our findings, we computed the correlation among TFs and well-recognized oncogenes to analyze their regulation pattern collectively. The objective here is to identify a small collection of common TFs that regulate a group of oncogenes. For instance, we observed that leukemia proto-oncogenes like BCR and DEK may be regulated sharing some common transcription factors. We also have similar results for the genes BTG1, FCGR2B and LCK. These results together with current biomedical literatures serve to corroborate our findings. Additionally, we also clustered the oncogenes based on their correlation with TFs and the results we report here support our earlier analysis.
Methods

Data preprocessing
As mentioned earlier, we analyzed expression data for both human and mouse to shortlist coexpressed genes with respect to TF. We collected microarray data of normal human tissues [48] , which provide us with 26,260 unique genes from 35 different organs. In total, the data set consists of 115 tissue specimens. 
Calculation of correlation coefficient
If a transcription factor does regulate a gene, according to reported results [12, 24] in the literature, it is expected that they are linearly correlated. However, we observed that very often there seems to be a saturation point where the effect on the expression level of the gene diminishes as the level of transcription factor continues to increase and may reach a plateau or even decrease in some cases (see Figure 1) . Again, Figure 2 shows the regulation pattern for inversely correlated TF and gene. In these plots, positive numbers represent the up-regulation of genes (or TF), while negative magnitudes for numbers stand for down-regulation of genes. Thus, instead of using simple linear correlation, we measure the correlation using Equation 1 as our regression curve. 
Finding cis-regulatory elements
To determine the (putative) cis-regulatory elements, we take advantage of the fact that our analysis is from tissue-specific microarray of two mammalian species, human and mouse. Thus, we can identify orthologous genes between the two species that we speculate to be associated with a common TF and analyze their promoter regions using sequence alignment to determine possible binding site for the TF [34] . For the human genome, we associate a TF as a possible enhancing or repressing regulatory element for a gene if the correlation coefficient is greater than 0.3 or less than -0.3, respectively. For the mouse genome, we have a more stringent threshold as the correlation coefficients are fairly high. The thresholds for positive and negative correlations are set at 0.4 and -0.4, respectively. Transcriptional regulatory elements are found either upstream or downstream of genes, scattered all along thousands of bps in both intergenic and intragenic regions. However, most TFBS predictors tend to focus in the proximal promoter region [52] because the difficulty of TFBS prediction tends to increase with the size of the region of interest. Besides, increasing the region of interest upstream of the transcription start site to more than a few thousand base pairs increases the chances of falsely identifying common repeat elements. Thus, we focus on the core promoter regions from 500 bps upstream to 200 bps downstream (-500 to +200, total 700 bps).
To ensure that our putative TF binding sites are of high quality, we validated them with TRANSFAC database [24, 53, 54] . TRANSFAC contains the largest repository for experimentally derived TFBS. We also performed further validations of our putative sites using P-Match [55] -public and ConSite [56] , which combines pattern matching and weight matrix approaches thus providing higher accuracy of recognition than each of the methods alone. To reduce false-positive validation using P-match, we chose "high quality vertebrate matrices only" as our default option. We obtained the report for all pre-selected genes, setting cut-off selection for matrices to minimize (1) false-positive, (2) false-negative, and (3) the sum of both error rates. Moreover, ConSite [56] is a user-friendly, web-based tool for finding cis-regulatory elements in genomic sequences using high-quality transcription factor models and cross-species comparison filtering.
Clustering the oncogenes
In order to explore the collective interactions among TF and oncogenes, we clustered the oncogenes with respect to regulating TFs. We constructed an interaction matrix, M, where each entry is either one (1) or zero (0) individually based on the correlation coefficients of the respective TF-gene pairs. For each possible pair of genes, if the number of one's along the rows exceeds a cut-off, we assign them in the same cluster. These pairs of genes will then be used as 'seeds' to grow the cluster in a greedy fashion, where new gene is added to the cluster if its putative TFBS are found to contain many of the putative TFBS of the genes already in the cluster. In each cluster, the correlations between TF and oncogenes are analyzed as a group to capture their differential regulation patterns.
Results and Discussion
Correlated genes and transcription factors
Using Pearson's Correlation Coefficient (see Methods section), we constructed a list of TFgene pairs, either correlated or inversely correlated to each other. Table 1 and Table 2 show the top ten most positively and negatively correlated genes and transcription factors for human (α = 0.25) and mouse (α = 0.5) in order. The complete list of correlated pairs can be obtained from our website [57] .
We find that many of the TF-gene pairs fit the non-linear function better, especially for the human genome. Using a threshold of +0.8 on the correlation coefficients, we find that the non-linear function seems to better depict the possible relationship between the TFs and genes, especially for the human genome. In our dataset for human, we have 1,114,432 possible TF-gene pairs. Of them, the number of correlated pairs are 171 (topmost 0.015%), 372 (0.033%) and 253 (0.023%) for α = 0.0 (linear), α = 0.25 and α = 0.50 respectively. Further, we observed that the correlation coefficients of most pairs are greater when α = 0.25 as opposed to α = 0.0. However, the effect on the mouse genome is not as dramatic, which is partly, we believe, due to the already higher linear correlation coefficient. Out of 4,52,076 possible TF-gene pairs, we found 2,448 (topmost 0.541%), 3,150 (0.70%) and 3,472 (0.77%) correlated TF-gene pairs for corresponding α = 0.0 (linear), α = 0.25 and α = 0.50 above +0.8 correlation coefficient. Therefore, our results concentrate on the correlated TF-gene pairs for human at α = 0.25, and for mouse α = 0.5. One of the novelties of our approach is that the technique can be scaled up by associating more genomes in the lineage, provided cis-elements are spatially conserved.
In the results for human expression data, we found that SCAND1 (SCAN domain containing 1) and RELB (v-rel reticuloendotheliosis viral oncogene homolog B) appear more often than others. SCAND1 is positively correlated with both ASGR1 (Asialoglycoprotein receptor 1) and F2 (Coagulation factor II (thrombin)), while RELB shows the same pattern with ATP2B1 (ATPase, Ca++ transporting, plasma membrane 1) and PSMB9 (Proteasome subunit, beta type, 9). In fact, the interactions between RELB and PSMB9 are reported in the literature [58] . As shown in Figure 1 , the regulation pattern among TFs and genes tends to better fit the decay function curve than simple linear line, which characterizes our assumption regarding TF-gene interaction model. In fact, we observed that the correlation coefficient of most TF-gene pairs tend to be higher for the non-linear function regressor than linear regressor. However, in the cases of anti-correlations, the coefficient numbers of TF-gene pairs are relatively low, which is possibly due to intrinsic experimental intricacy in measuring negativity in the gene expressions. Among the top short-listed pairs, PPARBP (PPAR binding protein), GABPA (GA binding protein transcription factor, alpha subunit 60kDa) and HCLS1 (Hematopoietic cell-specific Lyn substrate 1) showed up more frequently with corresponding down-regulated genes.
Our analysis of mouse expression data revealed that there are surprisingly strong correlations among genes in both directions, with 3,684 pairs having coefficient greater than 0.8 or below -0.8 as opposed to 372 in human. We believe that this is probably an artifact of the data. FOXE1 (Forkhead box E1) showed up most often in the positively correlated pairs, while MBP (Myelin basic protein) is the most frequently occurring in the negative list. Some TFs seemed to enhance the expression level of some genes while suppressing others. For example, LEF1 (Lymphoid enhancer-binding factor 1) and HOXB1 (Homeo box B1) are included in both positive and negative list. We screened out common genes that are co-expressed with these TFs. In order to quantify the conservation of regulatory elements along these gene sequences, the core promoter regions (see Methods) were fed to P-Match [55] using all three available options for handling false discoveries. Basically, the output with option "minimizing false negative" considers merely minimal number of base pairs match and calls it a hit. Thus it improves its recall numbers (maximize loose-bound relevance at the cost of precision), with a huge list of cis-element candidates. We expect the false-positive rate to be extremely high for the predictions to be meaningful. Therefore, we did not discard this option. Among the other options, "minimize false positive" tries to find exact (~100%) PWM match and accounts for the most precise TF hits. The other option "minimize sum of both error rates" seems to take advantage from the best of both worlds (keeping balance on both recall and precision) and evens out high false discovery rates. To ensure better quality of our analysis, we considered only the option "minimize false positive", which maximizes the precision values without compromising too much with recall values. We summarize the sample results (precision >= 50%) for both human and mouse genomes in Table 3 . The results for consulting ConSite are furnished as well. The consensus sequences (Logo-plots) for respective TFBS were extracted from TFMExplorer [17] .
Among eight TFs, our prediction performances for four TFs are encouraging while there is no highly correlated human pair showed up for the other four TFs. For instance, out of the 10 human genes that are associated with E2F5 (E2F transcription factor 5), a member of E2F TF family, 8 genes (80% hit rate) carry the supposed binding sites. Comparing the sequence patterns of binding sites, we can say that almost all of them share the consensus 'TTTSSCGC' where S could be a C or G. Out of these 8 human genes that are hit, 7 of the mouse orthologs also have the consensus sequence 'TTTSSCGC' in the promoter region.
As per validation, we reviewed biological literature and found that there is a strong association between E2F5 and EZH2 (enhancer of zeste homolog 2), which appears in our result for binding site predictions. The E2F transcription factors, considered to be oncogenes [59] , are key regulators of cell cycle progression [60] , apoptosis and DNA damage response [61] . Loss of E2F functionality results in acute developmental effects [62] . It is also evidenced that pRB-E2F pathway (The retinoblastoma protein-E2F) strongly regulates the expressions of Polycomb group genes (PcG), one of which is EZH2 [63, 64] . Again, EZH2 is downstream of the pRB-E2F pathway and it is up-regulated during the cell proliferation and down-regulated during the cell differentiation phases [65] .
Likewise, for the 14 human genes correlated with TF RELB, we have found 12 genes have the consensus sequence for RELB binding which achieve a hit rate of (85.71%). Among these 12 human genes, the mouse orthologs of 10 genes also contain some consensus sequence for RELB binding. Here, we found "TTTCC" as sense (+), or "GGAAA" as anti-sense (-) complementary, to be common motif with a number of out of pattern nucleotides around. Similarly, the precision rate for sp3 (Sp3 transcription factor) is 66.67% (4 hits out of 6 genes) and for STAT4 (signal transducer and activator of transcription 4) is 50% (1 hit from 2 genes). For sp3, listed genes have cis-elements containing motif "GCCAT" as sense (+), or "ATGGC" as anti-sense (-) counterpart. We believe that the hit rates for the rest are trivial due to the lack of sufficient correlated genes showing up.
Analyses of oncogenes
We selected a number of proto-oncogenes that are linked to various types of leukemia (AML, ALL, CML etc.) and breast cancer to illustrate our analyses. As discussed below, some correlated TF-gene pairs have been shown to bear regulatory relationship (Table 4 and Table  5 ). Moreover, some prospective candidates in our results actually comply with supporting biological literature reviews.
Leukemia genes
The BCR (Breakpoint cluster region) contains the Chromosome 22 breakpoint for the translocation that produces Philadelphia Chromosome [66] , which is very often found in patients with CML (Chronic Myelogenous Leukemia). The translocation occurs between BCR (in Chromosome 22) and ABL (v-abl Abelson murine leukemia viral oncogene homolog in Chromosome 9q34), and this reciprocal translocation creates a tyrosine kinase, which is self-activated. Eventually this complex speeds up cell division, inhibits DNA repair, and causes genomic instability and blast effect in CML. Our analysis shows that BCR is upregulated with NR2F6 and PCOLN3, which complements previous studies [67, 68] . Our other candidates are CENPB (Centromere protein B) and NCOR2 (Nuclear receptor co-repressor 2) as positively correlated transcription factors and SP3 (Sp3 transcription factor) as negatively correlated transcription factors.
One of the well-recognized oncogenes for AML (Acute Myelogenous Leukemia) is MLL (myeloid/lymphoid or mixed-lineage leukemia) [69] [70] [71] [72] . In our analysis, we found MDM2 (transformed 3T3 cell double minute 2, p53 binding protein), which is a potential target of tumor suppressor protein p53, to be up-regulated with MLL. Over-expression of MDM2 may cause excessive inactivation of tumor protein p53, deteriorating its tumor suppressor function [73, 74] .
The DEK (DEK oncogene) gene produces a fusion with the CAN protein in a subtype of AML patients [75] . We found HMGB1 (high-mobility group box 1) in our analysis, and it was also reported in the literature as a gene which controls the binding behavior of DEK [76] . Another transcription factor correlated with DEK is sp3 (Sp3 transcription factor) [77] .
We also furnished correlated transcription factors for LMO2 (LIM domain only 2), ETV6 (ets variant gene 6), RUNX1 (runt-related transcription factor 1, also called AML1), BTG1 (B-cell translocation gene 1, anti-proliferative) FCGR2B (Fc fragment of IgG, low affinity IIb, receptor, Loc. 1q23), LCK (lymphocyte-specific protein tyrosine kinase, Loc. 1p34.3), which are relevant to leukemia. Our analyses on oncogenes provide some supporting evidence for the correlations between transcription factors and corresponding genes. Most often, the findings are consistent with what we found in biological literature surveys. Also we find a number of significant candidates that may be quite relevant to cancer studies. For example, NR2F6, which is a nuclear receptor, is positively correlated with breast cancer gene (ErbB2) and one of the leukemia genes (BCR), while it is inversely correlated with other leukemia gene (DEK). Collectively, we may analyze the inter-relationships among leukemia genes and correlated transcription factors (see Table 6 ). Similarly, we discovered identical expression pattern among BTG1, FCGR2B and LCK genes (see Table 7 ). In fact, FCGR2B and LCK show up in the B-Cell Receptor Signaling Pathway and the T-Cell Receptor Signaling Pathway respectively, which seems to be the reason for this concurrence. 
Breast cancer genes
Unlike leukemia oncogenes, we applied our analysis on two well-known breast cancer genes, namely BRCA1 and ErbB2. Because of small number of genes, clustering is not feasible to discover the interactions. However, we found some associations among these genes, which are backed by literature.
Certain mutations of BRCA1 (Breast Cancer 1, early onset) cause approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] . Our analysis reveals that FOXM1, E2F1, PTTG1, HMGA1, GMEB1, MCM5 and HHEX transaction factor genes are positively correlated to the expression of BRCA1, while expressions of NFIB, EGR1, FOSB, and TBX3 appear to be inversely correlated to that of BRCA1. FOXM1 (Forkhead box M1) has been found to be responsible for epithelial ovarian tumors correlated with malignancy [90] and it is over-expressed in transcriptional regulations. There is much evidence that E2F1 (E2F transcription factor 1) is related to control of BRCA1. [95] . Substantial facts of TBX3 (T-box 3,) being correlated with BRCA1 has been also reported [96] . ErbB2/HER2 (HER2/neu, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/ glioblastoma derived oncogene homolog) [97] [98] [99] [100] [101] is a proto-oncogene located at 17q11.2-q12, 17q21.1 and belongs to the epithelial growth factor receptor (EGFR). It codes for a cell membrane surface-bound receptor tyrosine kinase that is expressed abundantly by transcriptional regulation in approximately 20%-40% of breast cancer and it is notably treated as a target gene for therapy. Often it plays a vital role in cell growth, differentiation and metastasis. We found several TFs, like NR2F6, RORC, TEAD3, IRX3, SOX13, PCOLN3, as positively expressed, and MEF2C, ZFP91, MEF2C, ZFP1 as negatively correlated with ErbB2. NR2F6 (Nuclear receptor subfamily 2, group F, member 6) was commented to be coupled with the expression of HER2 [68] . Also in-vitro studies showed that he phosphorylation of the exogenous MEF2C (Myocyte enhancer factor 2C) is dramatically increased by epithelial growth factor (EGF) and thus it refers to its association with controls of ErbB2 expression [102] .
regulatory relationship. As a measure of the quality of the predicted trans-elements, we focus on the set of transcription factors and genes that share the same gene names in both mouse and human data sets. Our analysis of oncogenes provides further assurance of the quality of the predicted trans-elements. Note that a highly correlated TF-gene pair that is not currently known to bear regulatory relationship may still be a correct trans-element prediction that is yet to be validated. ChIP-chip experiment is designed to test protein-DNA binding, where the binding of a transcription factor to a promoter region of a gene provides necessary but not sufficient evidence for transcription regulation. As a possible further step to confirm the regulatory relationship, the TF-gene pairs and their correlation coefficients constructed here may serve as a source of reference for additional confirmation of ChIP-chip results.
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